Ranibizumab versus verteporfin for neovascular age-related macular degeneration. (Q34652928)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Ranibizumab versus verteporfin for neovascular age-related macular degeneration. |
scientific article |
Statements
Ranibizumab versus verteporfin for neovascular age-related macular degeneration (English)
David M Brown
Mark Michels
Gisele Soubrane
Jeffrey S Heier
Robert Y Kim
Judy P Sy
Susan Schneider
ANCHOR Study Group
1 October 2006